Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritishttps://www.reddit.com/r/INCANNEX_IXHL_NASDAQ/s/mj8hDnufqP
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint